-transparent.png){kind=logo}
The contribution of granulocytes to differences in the innate susceptibility of mouse strains to infection by Salmonella typhimurium was assessed on the basis of the size and composition of the inflammatory exudate after i.p. injection of bacteria and the intracellular killing of the bacteria by exudate peritoneal cells and blood granulocytes of resistant CBA and susceptible C57BL/10 mice. The increase in the numbers of both peritoneal granulocytes and macrophages 24 hr after i.p. injection of various numbers of live S. typhimurium was two to four times higher in C57BL/10 mice (p less than 0.05) than in CBA mice. However, despite the larger number of phagocytes in the inflammatory exudate, the numbers of viable S. typhimurium in the peritoneal cavity 24 hr after injection was higher (p less than 0.01) in C57BL/10 mice than in CBA mice. Because the proportion of noningested bacteria was similar in the two mouse strains (less than 30%), these findings indicate a difference in the rate of intracellular killing of the bacteria by exudate peritoneal cells (greater than 75% granulocytes) of the two mouse strains. Subsequent determination of the initial rate of intracellular killing (Kk) of S. typhimurium revealed that after phagocytosis of the bacteria in vivo, exudate peritoneal granulocytes (harvested 24 hr after i.p. injection of 10(3) live S. typhimurium) of CBA mice killed S. typhimurium twice as efficiently (Kk = 0.014 min-1; p less than 0.01) as exudate granulocytes of C57BL/10 mice (Kk = 0.008 min-1) did. Similarly, the initial rate of intracellular killing of the ingested S. typhimurium by blood granulocytes of CBA mice (Kk = 0.017 min-1) was two times higher (p less than 0.01) than that of C57BL/10 mice (Kk = 0.007 min-1). These findings may be specific for S. typhimurium, because L. monocytogenes were killed with equal efficiency by exudate granulocytes and blood granulocytes of these mouse strains (p greater than 0.20). The results of the present study are relevant with respect to the innate resistance of mice to S. typhimurium, particularly during the initial phase of infection when the inflammatory exudate contains predominantly granulocytes.
J T van Dissel, and
J J Stikkelbroeck, and
W Sluiter, and
P C Leijh, and
R van Furth
May 1985,
Journal of immunology (Baltimore, Md. : 1950),
J T van Dissel, and
J J Stikkelbroeck, and
W Sluiter, and
P C Leijh, and
R van Furth
June 1992,
Journal of medical microbiology,
J T van Dissel, and
J J Stikkelbroeck, and
W Sluiter, and
P C Leijh, and
R van Furth
February 1982,
Immunology,
J T van Dissel, and
J J Stikkelbroeck, and
W Sluiter, and
P C Leijh, and
R van Furth
April 1981,
Journal of immunology (Baltimore, Md. : 1950),
J T van Dissel, and
J J Stikkelbroeck, and
W Sluiter, and
P C Leijh, and
R van Furth
March 1990,
Journal of medical microbiology,
J T van Dissel, and
J J Stikkelbroeck, and
W Sluiter, and
P C Leijh, and
R van Furth
January 1987,
The Journal of experimental medicine,
J T van Dissel, and
J J Stikkelbroeck, and
W Sluiter, and
P C Leijh, and
R van Furth
March 1996,
Infection and immunity,
J T van Dissel, and
J J Stikkelbroeck, and
W Sluiter, and
P C Leijh, and
R van Furth
July 1993,
Immunology,
J T van Dissel, and
J J Stikkelbroeck, and
W Sluiter, and
P C Leijh, and
R van Furth
June 1986,
Immunology,
J T van Dissel, and
J J Stikkelbroeck, and
W Sluiter, and
P C Leijh, and
R van Furth
April 1981,
Antimicrobial agents and chemotherapy,
